ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target Cancer Research UK to fully fund, sponsor, design, and execute CTA-enabling studies ...
Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) (NASDAQ: BMM) is pleased to announce additional assay results from its ongoing 18,000 m relogging campaign, including the second ...
Belgian physicist Francis Halzen has won the 2026 Nobel Prize in Physics for his pioneering work on the IceCube Neutrino ...
- Mineralys MLYS-- Therapeutics will present five lorundrostat abstracts at the AHA Hypertension meeting, but shares remain near 52-week lows despite the data. - The key decision remains the December ...
Kazakhstan plans to establish three joint research and development (R&D) centers focusing on alternative and renewable energy ...
Novonesis has completed its acquisition of Australian biotechnology company MicroBioGen after receiving all required regulatory approvals. The transaction builds on Novonesis' 201 ...
Colorectal cancers in people 20 and under are often aggressive and delayed in diagnosis, new research shows. Colorectal ...
Researchers at Chalmers University of Technology in Sweden have developed an AI scientist capable of generating scientific ...
For the first time, no hurricanes have formed in the Atlantic this season so far We’ve never had an Atlantic hurricane season without a single hurricane through the end of September—until now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results